Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market
NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.
I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India.
"Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now, creating an exciting new set of growth opportunities for U.S. investors in India," said CEO F. Jacob Cherian.
"I-AM Capital is focused on the fast growing technology, consumer and financial services sectors in India and through its Nasdaq listing offers US investors an innovative way to participate in this exciting growth opportunity," said CFO Suhel Kanuga.
"Nasdaq congratulates and welcomes I-AM Capital Acquisition Company to join our family of innovators," said Nelson Griggs, Executive Vice President, Head of Global Listings, Nasdaq. "I-AM Capital is the second Indian focused SPAC to list on Nasdaq this year, making it the 18th SPAC to IPO year to date joining the 34 successful business combinations completed by SPACs listed on Nasdaq since 2010. We look forward to supporting I-AM Capital's continued growth and success."
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Information about the company is provided by the company or comes from the company's public filings and is not independently verified by Nasdaq. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com
- NDAQG -
Media Relations Contacts:
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Mitratech23.4.2018 17:02 | pressemeddelelse
Mitratech Acquires ThinkSmart LLC to Create Industry-First, End-to-End Legal Operations Platform
Vricon23.4.2018 16:22 | pressemeddelelse
Vricon unveils new solution at GEOINT 2018: Vricon Precision 3D Registration (P3DR)
Abeona Therapeutics Inc23.4.2018 14:17 | pressemeddelelse
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
The Stevie Awards23.4.2018 04:02 | pressemeddelelse
Winners in 2018 Asia-Pacific Stevie® Awards Announced
Abeona Therapeutics Inc20.4.2018 14:16 | pressemeddelelse
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
Taconic Biosciences20.4.2018 14:02 | pressemeddelelse
Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum